Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial.

Autor: Cadegiani FA; Internal Medicine, Corpometria Institute, Brasilia, BRA., Zimerman RA; Infectious Disease, Hospital da Brigada Militar de Porto Alegre, Porto Alegre, BRA., Fonseca DN; Internal Medicine, Samel & Oscar Nicolau Hospitals, Manaus, BRA., Correia MN; Internal Medicine, Hospital Regional José Mendes, Itacoatiara, BRA., Muller MP; Surgery, Hospital Arcanjo São Miguel, Gramado, BRA., Bet DL; Internal Medicine, Hospital Unimed Chapecó, Chapecó, BRA., Slaviero MR; Physical Medicine and Rehabilitation, Hospital Arcanjo São Miguel, Gramado, BRA., Zardo I; Cardiology, Hospital Unimed Chapecó, Chapecó, BRA., Benites PR; Pulmonary and Critical Care, Hospital Unimed Chapecó, Chapecó, BRA., Barros RN; Internal Medicine, Hospital Municipal Jofre Cohen, Parintins, BRA., Paulain RW; Internal Medicine, Hospital Municipal Jofre Cohen, Parintins, BRA., Onety DC; Critical Care, Samel & Oscar Nicolau Hospitals, Manaus, BRA., Israel KCP; Nephrology, Samel & Oscar Nicolau Hospitals, Manaus, BRA., Gustavo Wambier C; Dermatology, The Warren Alpert Medical School of Brown University, Providence, USA., Goren A; Dermatology, Applied Biology Inc., Irvine, USA.

Publikováno v: Cureus [Cureus] 2021 Dec 25; Vol. 13 (12), pp. e20691. Date of Electronic Publication: 2021 Dec 25 (Print Publication: 2021).